The frequency of the carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii (CRACB) complex increases annually in our hospitals. However, the types and prevalence of carbapenemases among isolates still remain unclear. In this study, we identified and collected 672 carbapenem-resistant isolates from a medical center in Northern Taiwan between April and December of 2010. There were 577 genospecies 2 (Acinetobacter baumannii), 79 genospecies 13TU, and 16 genospecies 3 isolates. The isolates had an acquired bla OXA-24 -like gene, which was confirmed by sequencing for the encoded OXA-72 carbapenemase, and were often associated with high-level carbapenem resistance. These CRACB complex isolates remained susceptible to colistin (100%). The genotyping of isolates was conducted using pulsed-field gel electrophoresis with ApaI digestion. In most clonally related groups, patients were from both branch hospitals. The results indicate that interhospital dissemination of clones occurred. This study provides updated data on the types and prevalence of the CRACB complex. In addition, it presents a warning on the emergence and spread of CRACB complex harboring bla OXA-24 -like genes in northern Taiwan.
A
cinetobacter is an important nosocomial pathogen. Within the genus, the vast majority of species of clinical origin belong to the genetically closely related genospecies 2 (Acinetobacter baumannii), genospecies 13TU (AG13TU), and genospecies 3 (AG3). These genomic species are phenotypically similar and are collectively referred to as the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with genospecies 1 (Acinetobacter calcoaceticus). Carbapenems have been widely used for treating the multidrug-resistant A. calcoaceticus-A. baumannii complex. However, the carbapenem-resistant A. calcoaceticus-A. baumannii (CRACB) complex is increasingly reported as being caused by carbapenemhydrolyzing class D ␤-lactamases (CHDLs), including OXA-51-like, OXA-23-like, OXA-24-like, and OXA-58-like genes, or metallo-␤-lactamases (MBLs), including VIM, IMP, and SIM (1) . In addition to ␤-lactamases, carbapenem resistance in the A. calcoaceticus-A. baumannii complex might also result from porin or penicillin-binding protein modifications (2, 3) . According to an epidemiological investigation, the prevalence of the CRACB complex among nosocomial bacteria has risen in rank from the eighth (2006) to the first (2012) in our hospitals. This study analyzes the molecular characterization of carbapenemases in CRACB complex isolated in Taiwanese hospitals.
MATERIALS AND METHODS
Isolates and data collection. All clinical isolates of the CRACB complex with imipenem or meropenem MICs of Ն16 g/ml were collected from a medical center (comprising 2 branches) in northern Taiwan between April and December of 2010. The identification was performed using the VITEK2 system (bioMérieux Vitek Systems Inc., Hazelwood, MO). MICs were determined using the agar dilution method.
Pulsed-field gel electrophoresis (PFGE). Isolates were typed using PFGE (4) following the digestion of intact genomic DNA with ApaI (Biolabs). DNA fragments were separated using 1% (wt/vol) agarose gels in a 0.5% Tris-borate-EDTA (TBE) buffer by using a CHEF DRII apparatus (Bio-Rad, Hercules, CA) at 6 V/cm, pulsed from 5 to 20 s, for 19 h at 14°C (5) . A computer-assisted analysis was also performed using BioNumerics (Applied Maths, Sint-Martens-Latem, Belgium). Cluster analysis was performed using the unweighted pair group method with mathematical averaging (UPGMA), and DNA relatedness was calculated using the bandbased Dice coefficient for the whole profile. Isolates were considered to be of the same PFGE type if they were Ͼ87% similar.
PCR detection of carbapenemase genes and insertion sequences. The CHDL-and MBL-encoding genes were detected using PCR methods suggested previously by Woodford et al. (6) and Ellington et al. (7), respectively. PCR was used to detect the insertion sequence (IS) preceding the bla gene by using a forward primer of IS and a reverse primer of the TAA TGG CCT GTT CCC ATG TG  7  ISAba1B  CAT GTA AAC CAA TGC TCA CC  8  ISAba2A  AAT CCG AGA TAG AGC GGT TC  8  ISAba3C  AGC AAT ATC TCG TAT ACC GC  8  IS18B  ACC AGC CAT AAC TTC ACT CG  8  ISAba4A ATT TGA ACC CAT CTA TTG GC 9
OXA gene. All primers used in this study are listed in Table 1 . Sequence similarity searches were conducted using the BLAST program (http: //www.ncbi.nlm.nih.gov/blast).
RESULTS
Among the 672 nonrepetitive isolates of the CRACB complex, there are 577 Acinetobacter baumannii isolates, 79 genospecies 13TU (AG13TU) isolates, and 16 genospecies 3 (AG3) isolates. These isolates originated mainly from intensive care unit patients (62%). All the carbapenem-resistant A. baumannii (CRAB) isolates harbored the bla OXA-51 -like gene (Table 2 ). This gene is well known to be intrinsically located in A. baumannii isolates (8).
Other CHDL-encoding genes were detected. The bla OXA-23 -like gene was the most common (67.8%; 391/577) ( A. The CRACB complex isolates harbored the bla OXA-24 -like gene, the bla OXA-58 -like gene, and/or the IMP-1 gene, which were more frequently associated with a high level of carbapenem resistance (Fig. 1) . These acquired bla OXA-24 -like genes were confirmed by sequencing for encoding the OXA-72 carbapenemase. All CRACB isolates were also coresistant to cefpirome and remained susceptible to colistin (Table 3 ). All CRAB isolates were also coresistant to ceftazidime, ciprofloxacin, and gentamicin. The susceptibility rate was 3.8% for ampicillin-sulbactam and 36.9% for tigecycline. The CRAG13TU isolates still had a 48.1%, 53.2%, 75.9%, 70.9%, and 78.5% susceptibility rate to ampicillin-sulbactam, ceftazidime, ciprofloxacin, gentamicin, and tigecycline, respectively. The CRAG3 isolates had a 68.7%, 12.5%, 43.7%, and 56.2% susceptibility rate for ampicillin-sulbactam, ceftazidime, ciprofloxacin, and gentamicin, respectively. However, CRAG3 isolates were all still susceptible to tigecycline (100%).
Genotyping of isolates was conducted using PFGE with ApaI digestion. The results showed that CRAB isolates that harbored only the bla OXA-51 -like gene, both the bla OXA-51 -like gene and the bla OXA-23 -like gene, and both the bla OXA-51 -like gene and the bla OXA-24 -like gene (Fig. 2) exhibited 102, 227, and 7 distinct genotypes, respectively, which were classified into 12, 22, and 1 clonally related groups, respectively. CRAG13TU isolates exhibited 35 distinct genotypes, which were classified into 7 clonally related groups. CRAG3 isolates exhibited 12 distinct genotypes, which were classified into 5 clonally related groups. In most clonally related groups, patients were from 2 branch hospitals. Thus, the results indicate that the interhospital dissemination of clones had occurred.
DISCUSSION
An annual increase in the proportion of the CRACB complex in Taiwan from 17% in 2003 to 70% in 2013 was documented by the Taiwan Nosocomial Infection Surveillance (TNIS) System. According to the national surveillance data, the proportions of the CRACB complex in Taiwan were higher than those in the United States and Europe. In our study, the CRAB isolates that carry the bla OXA-23 -like gene were the most common (67.8%). Kuo et al. reported that the occurrence of the bla OXA-23 -like gene was 58% in hospital C in northern Taiwan (9) . A report from South Korea revealed that the occurrence of the bla OXA-23 -like gene was 77% (10) . These results are similar to those in our report. However, a report from another medical center in northern Taiwan revealed that only 3.4% of CRAB isolates harbored the bla OXA-23 -like gene (11) . Reports from 2 hospitals in central Taiwan showed a higher occurrence of the bla OXA-23 -like gene (93% and 96%, respectively) (12, 13) . Meanwhile, the bla OXA-23 -like gene was less common (0% and 1.1%, respectively) in 2 hospitals in southern Taiwan (14, 15) . The prevalence of CRAB isolates carrying the bla OXA-24 -like gene in our study was 2.2%, a result that is similar to those reported by 2 other hospitals in northern Taiwan (3% and 3.4%, respectively) (9, 11) but differs from those reported by the hospitals in central Taiwan (0% and 0.5%, respectively) (12, 13) and southern Taiwan (14% and 64%, respectively) (14, 15) . We propose that the types and prevalence of CHDLs among CRAB isolates might display great geographical differences.
The presence of IS elements upstream of the bla OXA-51 -like genes, bla OXA-23 -like genes, and bla OXA-58 -like genes indicates that they might play a role in their expression by providing promoter sequences. Although the CHDLs encoded by these genes have a relatively weak ability to hydrolyze carbapenems, these enzymes might be overexpressed, resulting in resistance to carbapenems. In isolates containing the bla OXA-51 -like gene but not containing ISAba1 upstream, their resistance to carbapenems might be ex- (18) . Their findings show that Xer recombination might be responsible for mobilizing the bla OXA-24 -like gene. Further experiments will be conducted to confirm this hypothesis. Large-scale surveys on the prevalence of these carbapenemase genes throughout Taiwan remain scarce. The present study not only demonstrates updated data regarding the molecular epidemiology of carbapenemases in the CRACB complex but also warns of the emergence and spread of the CRACB complex harboring the bla OXA-24 -like gene in northern Taiwan.
